MeSH D020790 - neurogenic diabetes insipidus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Novast Laboratories | Desmopressin | Desmopressin | 2019-06-06 | |||
| Glenmark Pharmaceuticals | Desmopressin | Desmopressin | 2015-05-28 | |||
| NATCO Pharma | Desmopressin | Desmopressin | 2014-06-27 | |||
| Bausch Health Companies | Desmopressin | Desmopressin | 1999-01-25 | |||
| Dr Reddys Laboratories | Desmopressin | Desmopressin | 2022-08-19 | |||
| Zydus Therapeutics | Desmopressin | Desmopressin | 2017-10-03 | |||
| Sun Pharmaceutical Industries | Desmopressin | Desmopressin | 2012-04-12 | |||
| Apotex | Desmopressin | Desmopressin | 2005-01-27 | |||
| Hospira | Desmopressin | Desmopressin | 2000-08-28 | |||
| Impax Laboratories | Desmopressin | Desmopressin | 2006-01-25 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/1
Phase 2
0%0/0
Phase 3
100%2/2
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use